Liver Injury Secondary to Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease: A Case Series and Review of the Literature
Background. Biologic therapy to inhibit tumor necrosis factor-alpha (TNF-α) is an effective, safe treatment for patients with inflammatory bowel disease (IBD). All TNF-α inhibitors have been associated with liver toxicity, but many of these cases have been reported in patients receiving therapy for...
Main Authors: | Ravish Parekh, Nirmal Kaur |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Case Reports in Gastrointestinal Medicine |
Online Access: | http://dx.doi.org/10.1155/2014/956463 |
Similar Items
-
Tumor Necrosis Factor Alpha Inhibition for Inflammatory Bowel Disease after Liver Transplant for Primary Sclerosing Cholangitis
by: Ravish Parekh, et al.
Published: (2018-01-01) -
Anti-TNF Withdrawal in Inflammatory Bowel Disease
by: Joana Torres, et al.
Published: (2016-05-01) -
Rate and predictors of mucosal healing in patients with inflammatory bowel disease treated with anti-TNF-alpha antibodies.
by: Florian Beigel, et al.
Published: (2014-01-01) -
ANTI-CYTOKINE (ANTI-TNF-ALPHA) THERAPY IN OPHTHALMOLOGY (REVIEW OF LITERATURE)
by: N. A. Gavrilopva, et al.
Published: (2015-12-01) -
Anti-cytokine (anti-TNF-alpha) therapy in ophthalmology (review of literature)
by: N.A. Gavrilopva, et al.
Published: (2013-02-01)